))
Aurrigo's 160% Surge, Oxford Drug Design Funding, Fossil-Free Fuel at National Oceanography Centre
Manage episode 442961240 series 3522529
Content provided by The Business Magazine. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Business Magazine or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
These are the top stories making the headlines across The Business Magazine website today:
Aurrigo International sees strong growth in autonomous division in first half
Coventry-based Aurrigo International plc reported a significant first-half growth in its autonomous ground handling technology division, achieving £800,000 in revenue—a 160% increase— and projecting annual sales to reach £3 million.
Full story here: https://thebusinessmagazine.co.uk/companies/aurrigo-international-sees-strong-growth-in-autonomous-division-in-first-half/
Oxford Drug Design set to help advance new treatments for CF lung infections
Oxford Drug Design has received £466,000 from the Cystic Fibrosis Antimicrobial Resistance Syndicate’s £3 million Collaborative Discovery Programme, funded by LifeArc, to develop new treatments targeting bacterial infections in Cystic Fibrosis patients using AI technology.
Full story here: https://thebusinessmagazine.co.uk/companies/oxford-drug-design-set-to-help-advance-new-treatments-for-cf-lung-infections/
Southampton’s National Oceanography Centre trials low-carbon fuel
On World Maritime Day, Southampton’s National Oceanography Centre marked the occasion by successfully trialing fossil-free marine diesel made from hydrotreated vegetable oil (HVO) on two of its Royal Research Ships, James Cook and Discovery.
Full story here: https://thebusinessmagazine.co.uk/esg/southamptons-national-oceanography-centre-trials-low-carbon-fuel/
232 episodes
Share
